Send Message
Home > products > Anti-Tumor > Enasidenib mesylate (1650550-25-6)

Enasidenib mesylate (1650550-25-6)

Product:
Enasidenib Mesylate
Description:
CAS: 1650550-25-6; Enasidenib manufacturer; Enasidenib API; Anti-tumor
Category:
Anti-Tumor
In-stock:
In Stock
Payment Method:
L/C, T/T
Shipping Method:
AIR, Express
Specifications
CAS:
1650550-25-6
Specification:
CP, EP, As Required
M.F.:
C20H21F6N7O4S
M.W.:
569.48
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Introduction

Enasidenib is a first-in-class oral selective inhibitor of mutant IDH2 enzymes (isocitrate dehydrogenase 2), for the treatment of adults with relapsed or refractory IDH2-mutated acute myeloid leukemia.

 

Enasidenib mesylate (1650550-25-6) 0

 

Product Name: Enasidenib mesylate
CAS No.: 1650550-25-6
Assay: 98%
Specification: CP, EP, In-house, as required
Molecular Formula:

C20H21F6N7O4S

Molecular Weight:

569.48

Shelf Life: 2 Years
Package: 25kg/drum

 

Enasidenib mesylate (1650550-25-6) 1

Enasidenib mesylate (1650550-25-6) 2

Enasidenib mesylate (1650550-25-6) 3

Send RFQ
Stock:
In Stock
MOQ: